A Bayesian Approach for PK/PD Modeling with PD Data Below Limit of Quantification

By Zhou Huafeng  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1220-1243

Taylor & Francis Ltd

Access to resources Recommend Favorite

Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development

By Geerts Hugo  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 257-265

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes

By Zager Michael   Kozminski Kirk   Pascual Bernadette   Ogilvie Kathleen   Sun Shaoxian  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 127-139

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study

By Höcht Christian   Di Verniero Carla   Opezzo Javier   Bramuglia Guillermo   Taira Carlos  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 4, 2006-07 ,pp. : 310-318

Springer Publishing Company

Access to resources Recommend Favorite

Streamlining the PK/PD data transfer process

By Collins Arthur  

Pharmaceutical Programming, Vol. 3, Iss. 1, 2010-06 ,pp. : 24-28

Maney Publishing

Access to resources Recommend Favorite